By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NeoPharm Inc. 

100 Corporate North, Suite 215

Bannockburn  Illinois  60015  U.S.A.
Phone: 847-295-8678-Ext-115 Fax: 847-295-8854


Company News
Prima Biomed (PRR.AX) And NeoPharm (NEOL) Execute Final Agreement For CVac License 2/21/2014 9:36:42 AM
Prima Biomed (PRR.AX) and NeoPharm (NEOL) Enter Into License for CVac in Israel 11/6/2013 10:40:13 AM
Apricus Biosciences (APRI) and NeoPharm (NEOL) Sign Licensing Agreement for Vitaros(R) in Israel for up to $4.35 Million, Plus Royalties 2/14/2011 9:59:45 AM
Dr. Daniel Von Hoff Joins INSYS Therapeutics/NeoPharm (NEOL) as Chief Development Officer 1/7/2011 9:47:47 AM
Dr. Daniel Von Hoff Joins INSYS Therapeutics/NeoPharm (NEOL) As Chief Development Officer 1/6/2011 11:39:41 AM
NeoPharm (NEOL) Completes Merger with INSYS Therapeutics 11/10/2010 10:42:54 AM
NeoPharm (NEOL) Announces Merger with INSYS Therapeutics 11/1/2010 10:05:18 AM
NeoPharm (NEOL) Announces Second Quarter 2010 Financial Results 8/26/2010 8:27:40 AM
NeoPharm (NEOL) Announces First Quarter 2010 Financial Results and Clinical Trial Update 6/11/2010 9:46:12 AM
NeoPharm (NEOL) Announces FDA Grant of Orphan Drug Designation for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis 5/17/2010 10:00:46 AM